ST2

Measuring the level of ST2 in blood for prognosis of heart failure

ST2 signals the presence and severity of adverse cardiac remodeling and tissue fibrosis, which occurs in response to myocardial infarction, acute coronary syndrome, or worsening heart failure. This test provides prognostic information, which is independent of other biomarkers used to probe the cardiac event.